Assertio Holdings, Inc. ASRT NASDAQ

Assertio Holdings, Inc. (ASRT) reported total assets of $266.97M and total liabilities of $173.02M for fiscal year 2025, resulting in total equity of $93.95M.

The company held $63.41M in cash and short-term investments. Total debt stood at $39.12M, with net debt of $28.9M. The Debt-to-Equity (D/E) ratio was 0.42 (conservative).

Current ratio is 1.7, indicating strong short-term liquidity. Interest coverage is -7x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (43/100) — Total assets $266.97M and equity $93.95M support the company's competitive scale
• VALUE (43/100) — Debt-to-Equity 0.42 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 31/100 with 0/7 criteria passed.

ITCI

Intra-Cellular Therapies, Inc.

$131.87

+0.00%

NBIX

Neurocrine Biosciences, Inc.

$130.81

+3.55%

CTLT

Catalent, Inc.

$63.48

+0.00%

RDY

Dr. Reddy's Laboratories Limited

$13.13

-1.06%

ALKS

Alkermes plc

$33.87

+0.36%

AMRX

Amneal Pharmaceuticals, Inc.

$13.12

+2.26%

DCPH

Deciphera Pharmaceuticals, Inc.

$25.59

+0.08%

ANIP

ANI Pharmaceuticals, Inc.

$78.29

-0.03%